DV
Dividend Vision

BCAB — Bioatla Inc

Bioatla Inc (BCAB)

Total return is -99.8% over the past 5.7 years, 226.6 points behind SPY at 126.8%. Its deepest 1-year drawdown was 94.7%.

BCAB is an equity fund that tracks Bioatla Inc, a single-stock holding in the biotechnology sector. The fund lacks a meaningful dividend distribution rate and does not currently provide regular income distributions. This holding appeals primarily to investors seeking concentrated exposure to a biotech company rather than those pursuing dividend income strategies.

BCAB key facts

Asset type
Stock
Asset class
Equity
Inception date
12/16/2020
Last close
$3.09
Market cap
$6,555,238
Average volume
144034.0
Beta
0.75
Payout ratio
0.0
Forward P/E
0.0
EPS
$-41.56